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Schistosomiasis (bilharzia) is a parasitic helminth disease that can cause severe
inflammatory pathology leading to organ damage in humans. Failure of the host to
regulate egg-driven granulomatous inflammation causes host morbidity during chronic
infection with Schistosoma mansoni. Although the importance of B cells in regulating
pathology during chronic infection has been well defined, the specific contribution
of IL-4Rα-expressing B cells is still unknown. To address this, we examined B
cell-specific IL-4Rα-deficient (mb1creIL-4Rα−/lox) mice in three experimental models of
schistosomiasis: high-dose (100 cercariae), low dose (30 cercariae), and a synchronous
egg challenge. In the high dose model, we found that mice deficient in IL-4Rα-expressing
B cells were more susceptible to acute schistosomiasis than B cell-deficient (µMT)
mice, succumbing to infection at the acute stage whereas µMT mice survived until the
chronic stage. An S. mansoni egg challenge model demonstrated that deleting IL-4Rα
expression specifically on B cells resulted in increased lung granulomatous pathology,
suggesting a role for this B cell subset in controlling granulomatous pathology. In
agreement with this, a low dose model of schistosomiasis—which mimics the course
of clinical chronic disease—demonstrated that depleting IL-4Rα-expressing B cells
in mb1creIL-4Rα−/lox mice considerably impaired the host ability to down-modulate
granulomatous inflammation in the liver and gut during chronic schistosomiasis. Taken
together, our findings indicate that within the B cell compartment, IL-4Rα-expressing
B cells in particular down-modulate the deleterious egg-driven tissue granulomatous
inflammation to enable host survival during schistosomiasis in mice.
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INTRODUCTION
The ability of B cells to drive host protective defense
mechanisms during parasitic infections has received a lot of
attention of late. Studies from over two decades ago utilized
B cell deficient mice (µMT) that were generated by targeting
the IgM transmembrane domain, resulting in the impairment
of the B cell compartment. B cell-deficient mice were found
to be susceptible to schistosomiasis, succumbing to infection
at the chronic stage of disease, and displaying augmented liver
granulomatous pathology (1, 2). Moreover, B cells have been
shown to be crucial for the development of host protective
effector and memory CD4+ T cells responses to Pneumocystis
lung infection (3). In contrast, B cells are dispensable for driving
host protective immunity to infection with the intracellular
parasite Leishmania major (L. major), with B cell-deficient mice
developing intermediate resistance to the infection between
Balb/c and C57BL6 mice (4).
The general contribution of B cells to host immunity against
infection is well established, and recent studies focus on specific
subsets of B cells and B cell-derived effector molecules. A
pioneering study by Harris et al. classified B cells into two effector
subsets: B effector 1 (Be1) cells that secrete IFN-γ, IL-12p40,
and TNF-α under the control of the transcription factor T-bet
(5, 6) and B effector 2 (Be2) cells that produce low IL-4, IL-13,
and IL-2 after receiving instruction from IL-4, IL-4Rα, and Th2
cells (5, 7, 8). The latter subset was identified in vitro and in
vivo after infection with H. polygyrus. We have recently shown
that IL-4-producing B cells influence T helper cell dichotomy
within the first 3 days of infection in the lymph node, which
leads to a host protective type 2 immune response during acute
schistosomiasis but is detrimental to the host during cutaneous
leishmaniasis caused by L. major (9). Moreover, B cell-derived
IL-2, and TNF-α are crucial for clearance of Heligmosomoides
polygyrus (H. polygyrus) worms, development of CD4+ T cells
secreting IL-4 and generation of type 2 antibody responses (10).
Another key molecule derived from B cells that is crucial for the
development of robust host defense mechanisms is the MHCII
molecule, and mice carrying a specific deletion of MHCII on B
cells failed to clear H. polygyrus infection and exhibited impaired
humoral and cellular immunity (10).
Schistosomiasis is an important parasitic disease that affects
more than 200 million people worldwide and is estimated to
cause approximately 280 000 deaths per year in sub-Saharan
Africa alone (11–14). The disease is caused by trematode
flukes of the genus Schistosoma; mainly, Schistosoma mansoni
(S. mansoni), S. japonicum and S. haematobium, which are
infective to humans (11–13). The disease is driven by the
thousands of eggs that become trapped in host tissues such as
the liver, kidneys and intestines, triggering a robust immune-
mediated granulomatous inflammation. This causes local and
systemic manifestations like anemia, growth stunting, impaired
cognition, hepatosplenomegaly, periportal fibrosis, urogenital
inflammation, and scarring that ultimately lead to host morbidity
and eventual death in some severe cases (11). The immune
response is characterized by a triphasic kinetic, with phase
1 dominated by a Th1 response induced by worm antigens,
phase 2 (acute stage) characterized by an egg-driven, highly
polarized Th2 granulomatous response, and immunomodulatory
responses occurring in phase 3 (chronic stage) (15, 16).
Earlier studies aimed at elucidating the immunological
factors driving host protective immunity to schistosomiasis took
advantage of constitutive gene-deficient mouse models. These
studies demonstrated that T and B cells (17–21) and Th2 effector
molecules (IL-4, IL-13, IL-10, IL-4Rα, STAT-6) are crucial for
conferring host protective immunity to infection (22–31). In
our laboratory, we have looked in more detail at the cell-
specific requirements of IL-4Rα in driving host survival during
S. mansoni infection. We have found that IL-4Rα signaling
on macrophages and neutrophils (32), smooth muscle cells
(33), and pan-T cells (34) individually contribute to driving
host protective immunity and down-modulating excessive tissue
pathology during acute schistosomiasis.
For the host to survive the chronic stage of S. mansoni
infection, the dominant Th2 immune response driven by the
eggs needs to be down-regulated to enable the host to control
the fibrogranulomatous damage (1, 35–40). Immuno-suppressive
CD8+ T cells (36), cross-regulation by cytokines produced by
Th1 or Th2 cells (26, 37, 38) and FcR signaling on B cells
(1, 2) have all been implicated in the immunomodulatory
mechanisms required to ameliorate tissue pathology during
chronic schistosomiasis. The immunomodulatory role of B cells
was accidentally demonstrated in a study that targeted IL-10R
using antibodies and found that B cells were depleted in the
liver with a consequent augmented pulmonary granulomatous
pathology during chronic schistosomiasis (41).
In this study, we investigated the immunomodulatory role
of IL-4Rα expressing B cells during schistosomiasis. Using
transgenic mice that lacked IL-4Rα expression on B cells
(mb1creIL-4Rα−/lox), we showed that mice lacking this subset
of B cells are susceptible to schistosomiasis, succumbing to
disease earlier than both littermate controls and global B cell
deficient mice. We found that the lack of IL-4Rα expressing B
cells resulted in augmented granulomatous pathology in the liver
and gut, and a profound inflammatory response characterized
by increased concentrations of IL-4, IL-5, IL-6, IFN-γ, and
IL-17 at the later stages of chronic schistosomiasis infection.
Finally, in situ analysis revealed that mice lacking B cell-specific
IL-4Rα expression failed to down-regulate granulomatous lung
pathology after synchronous S. mansoni eggs challenge. Taken
together, these findings demonstrated that IL-4Rα expressing B
cells play a crucial immunomodulatory role that limits T cell
responses and granulomatous tissue pathology during chronic
schistosomiasis.
RESULTS
Mice Lacking IL-4Rα Expressing B Cells
Are More Susceptible to Schistosomiasis
Than B Cell-Deficient Mice
A previous study showed that mice deficient in B cells
displayed heightened susceptibility to schistosomiasis at the
chronic stages of infection (1, 2). Moreover, we have recently
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FIGURE 1 | Mice lacking IL-4Rα expressing B cells succumb to schistosomiasis by 10 weeks post-infection. IL-4Rα−/lox, mb1cre IL-4Rα−/lox and µMT mice were
infected with 100 S. mansoni cercariae and monitored weekly. (A) Survival kinetics of mice infected with S. mansoni (n = 8–10 mice). Survival curves were compared
using Logrank test. *p < 0.05 and **p < 0.01 vs. IL-4Rα−/lox mice. (B) Granuloma area measured by microscopic analysis of formalin-fixed liver sections after H&E
staining. (C) Liver fibrosis measured as hydroxyproline content normalized to tissue egg numbers (mean ± SEM, n = 4–6). (D) Cytokine production by total
mesenteric lymph node cells restimulated with either SEA. (E) Cytokine production by total mesenteric lymph node cells restimulated with α-CD3 (mean ± SEM, n =
8–10 mice). Data are representative of two independent experiments. *p < 0.05, **p < 0.01 and ***p < 0.001 vs. IL-4Rα−/lox mice.
shown that mb1creIL-4Rα−/lox mice, which lack IL-4Rα
expression specifically on B cells, are highly susceptible to acute
schistosomiasis and display increased hepatocellular damage
(9). To investigate whether IL-4Rα expressing B cells contribute
to the B-cell mediated host resistance to schistosomiasis, we
infected mb1creIL-4Rα−/lox, µMT and IL-4Rα−/lox mice with
100 live S. mansoni cercariae and monitored them over a 13
weeks period. Mb1creIL-4Rα−/lox mice began to die at 7 weeks
post-infection and they had all succumbed to infection by
10 weeks post-infection compared to littermate control mice
that had 50% survival at the same time point (Figure 1A).
In contrast, B cell-deficient (µMT) mice displayed delayed
susceptibility when compared to Mb1creIL-4Rα−/lox mice,
with mice surviving the acute stage of infection (Figure 1A).
However, during the chronic stage of infection, B cell deficient
mice had a drastic increase in mortality rate, with 50% of mice
succumbing to infection within the same week (Figure 1A).
Taken together, these data suggest that the specific deficiency of
IL-4Rα expressing B cells is equally if not more deleterious to the
host than the general lack of B cells during acute schistosomiasis.
Liver granuloma formation was compared betweenmb1creIL-
4Rα−/lox mice and µMT mice at 7 weeks post S. mansoni
infection. As observed previously, B cell-specific IL-4Rα deficient
mice had augmented granuloma size compared to littermate
control mice (Figure 1B). However, the granulomas from B
cell deficient mice were larger than the granulomas from B
cell-specific IL-4Rα deficient mice (Figure 1B). In fact, B cell
deficient mice developed granulomas that were almost twice
the size of those from littermate IL-4Rα−/lox mice (Figure 1B)
confirming a central role for B cells in the control of the host
granulomatous response during schistosomiasis. However, livers
from µMT mice contained almost double the concentration of
hydroxyproline than both the mb1creIL-4Rα−/lox and littermate
control mice during the acute phase of infection, indicating
increased hepatic fibrosis in the absence of total B cells
but not specifically IL-4Rα expressing B cells (Figure 1C).
These data suggest that whereas IL-4Rα expressing B cells
contribute to the control of the liver granulomatous response
during schistosomiasis, other unidentified B cell subset(s) is(are)
similarly important. Intriguingly, however, our findings also
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FIGURE 2 | IL-4Rα expressing B cells are required to down-regulate hepatic pathology during chronic schistosomiasis. IL-4Rα−/lox, mb1cre IL-4Rα−/lox, and
IL-4Rα−/lox mice were infected with 30 S. mansoni cercariae and killed at 16 and 24 weeks post-infection. (A) Liver granuloma area was measured using a
computerized morphometric analysis program (NIS elements by NIKON) by measuring 20–25 granulomas per mouse. (B) Serum IL-4 levels were detected by ELISA
at both time points. (C,D) Detection of cytokine production by total MLN cells after in vitro restimulation with α-CD3 for 72 h. (E) Histology images showing liver
granuloma formation at 16 and 24 weeks post-infection. Data represent two independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 vs. IL-4Rα−/lox mice. n =
4–6 mice per group.
indicate that B cells mediate the down-regulation of hepatic
fibrosis in this context independently from IL-4Rα expressing B
cells.
We further restimulated MLN cells from infected mice with
either Schistosoma egg antigen (SEA) or α-CD3 in vitro and
measured cytokine production by ELISA. In accordance with
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our recent report (9), cells from mb1creIL-4Rα−/lox mice failed
to produce the Th2 cytokines IL-4, IL-5, and IL-10 in response
to antigen-specific stimuli compared to littermate control mice
(Figure 1D). Similarly, cells from µMT mice stimulated with
SEA failed to produce IL-4 and IL-10 although the levels of IL-
5 were the same as those in littermate control mice (Figure 1D).
Conversely, mitogenic stimulation of cells from µMT mice
triggered a substantial release of IL-10 and IFN-γ while the
production of IL-4 was diminished compared to littermate
control mice (Figure 1E). Finally, in comparison to littermate
control mice, cells from B cell-specific IL-4Rα deficient mice
showed defects in the production of IL-4 and IL-5 while the
production of IL-10 and IFN-γ was unaltered after restimulation
with α-CD3 (Figure 1E). In as much as our data unveil a
differential immune responsiveness between cells fromµMT and
mb1creIL-4Rα−/lox mice when compared to littermate control
IL-4Rα−/lox mice, they demonstrate a similar need for total B
cells and IL-4Rα expressing B cells in driving the development
of optimal Th2 responses during S. mansoni infection in vivo.
To explore the impact of IL-4Rα deficiency on B cells on
the differentiation and cytokine production by CD4+ T cells
during infection, single cell suspension was prepared from MLN
and cells were stained for flow cytometry analysis. There was
no significant difference in the absolute number of CD3+CD4+
T cells present in the MLN in all mutant mouse strains
(Figure S1A). However, the lack of IL-4Rα expression on B cells
significantly hindered the differentiation of CXCR5+ TFH cells
(Figure S1B) and effector CD4+ T cells (CD4+CD44hiD62Llo,
Figure S1C) compared to littermate control mice. Similarly, B
cell deficient mice exhibited reduced numbers of CXCR5+ TFH
cells and effector CD4+ T cells compared to littermate control
mice (Figures S1B,C). Examination of intracellular cytokine
production by CD4+ T cells restimulated with PMA/Ionomycin
ex vivo revealed that abrogation of IL-4Rα expression on B
cells results in reduced production of Th2 cytokines IL-4 and
IL-13 albeit IFN-γ production was not altered compared to
control mice (Figure S1D). Likewise, CD4+ T cells from µMT
mice failed to produce Th2 cytokine IL-4 and IL-13 after ex
vivo restimulation with PMA/Ionomycin compared to littermate
control mice (Figure S1D). Therefore, IL-4Rα expression on B
cells is crucial for differentiation of CD4+ T cells and generation
of CD4+ Th2 immunity.
B cells have been shown to produce cytokines in response to
antigen-specific stimulation or in vivo during infection (13). To
explore the ability of IL-4Rα deficient B cells to produce cytokines
during S. mansoni infection, single cell suspension was prepared
from MLN and cells restimulated with PMA/Ionomycin before
intracellular cytokine detection by flow cytometry analysis.
The absolute number of CD19+B220+ B cells was comparable
between both mutant strains (Figure S1E). However, the
total number of follicular B cells (B220+CD21hiCD23hi) was
significantly reduced in mb1creIL-4Rα−/lox mice (Figure S1F),
while the number of marginal zone B cells was significantly
increased compared to littermate control mice (Figure S1G). We
observed a general abrogation of cytokine producing B cells
in B-cell-specific IL-4Rα-deficient mice compared to littermate
control mice (Figure S1H). Therefore, these data suggests that
B cell-specific IL-4Rα expression is required for initiating
expression of type 1 and type 2 cytokine during helminth
infection.
IL-4Rα Expressing B Cells Are Required for
Containment of Granulomatous Pathology
During Chronic Schistosomiasis
To further assess the suggested importance of IL-4Rα expression
on B cells for the down-regulation of S. mansoni egg-
driven fibrogranulomatous inflammation, we performed a low
dose infection of mb1creIL-4Rα−/lox mice (30 live S. mansoni
cercariae) and killed mice at 16 (chronic) and 24 (advanced
chronic) weeks post-infection to analyse tissue pathology
and immune profiles of chronically infected mice. We did
not observe any significantly different mortality between the
mutant strains during the entire course of chronic S. mansoni
infection (Table S1). Mice lacking IL-4Rα expressing B cells had
significantly enlarged granulomas in the liver at both 16 and
24 weeks post-infection compared to littermate control mice
(Figures 2A,E). Interestingly, although the levels of serum IL-
4 were significantly reduced in infected mb1creIL-4Rα−/lox mice
at 16 weeks post-infection, the levels of IL-4 were almost 3-fold
higher in mice lacking IL-4Rα expressing B cells at 24 weeks post-
infection (Figure 2B). Analysis of the cytokine profile produced
by total MLN cells restimulated with 20µg/ml of α-CD3 revealed
that the production of IL-10 was significantly decreased in
mb1creIL-4Rα−/lox mice compared to littermate control mice
while the concentrations of IL-4, IL-5, and IFN-γ were similar in
all mutants at 16 weeks post-infection (Figure 2C). In contrast,
mb1creIL-4Rα−/lox mice developed significantly increased levels
of IL-4, IL-10, IL-6, IL-17, and IFN- γ compared to IL-4Rα−/lox
littermate control mice at 24 weeks post infection (Figure 2D).
Therefore, the data strongly suggested that IL-4Rα expressing B
cells are required to down-regulate both hepatocellular damage
and general cytokine responses during the late stages of chronic
schistosomiasis.
We also investigated whether IL-4Rα expressing B cells were
required to downregulate gut pathology during the chronic stages
of schistosomiasis. Infected mb1creIL-4Rα−/lox mice developed
large granulomas in the small intestines at 16 weeks post-
infection and these became even larger at 24 weeks post-
infection (Figure S2). In contrast, littermate control mice were
able to modulate gut granulomatous pathology as indicated
by the presence of small granulomas characterized by minor
infiltration of immune cells (Figure S2). We also observed a
comparable number of S. mansoni eggs shunted into the lungs
in both mb1creIL-4Rα−/lox mice and IL-4Rα−/lox littermate
control mice at both 16 and 24 weeks post-infection (Figure S3)
Therefore, these data demonstrate that IL-4Rα expressing B cells
are essential for down-regulating gut granulomatous pathology
during chronic schistosomiasis in mice.
IL-4Rα Expressing B Cells Are Required to
Control Lung Granulomatous Pathology
During Synchronous S. Mansoni egg
Challenge
Since we had observed shunting of eggs to the lungs in
both mb1creIL-4Rα−/lox and IL-4Rα−/lox mice, we used a
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FIGURE 3 | Mice lacking IL-4Rα expressing B cells fail to down-regulate early granulomatous pathology in the lungs after synchronous S. mansoni eggs challenge.
IL-4Rα−/lox and mb1cre IL-4Rα−/lox mice were sensitized with 2 500 S. mansoni eggs intraperitoneally, challenged with 2 500 eggs intravenously 14 days later and
killed over two time points (7 and 14 days post-challenge). (A) Granuloma formation was measured using a computerized morphometric analysis program (NIS
elements by NIKON) by measuring 20–25 granulomas per mouse. (B) Lung fibrosis measured by determining hydroxyproline concentration. (C) Histological
examination of H&E stained lungs sections. Data represent two independent experiments. *p < 0.05, **p < 0.01 and ***p < 0.001 vs. IL-4Rα−/lox mice. n = 6 mice.
synchronous S. mansoni egg model where mice were first
sensitized then challenged with 2,500 S. mansoni eggs to validate
the effect of IL-4Rα expressing B cells on S. mansoni egg-driven
fibrogranulomatous responses. Comparatively testing mb1creIL-
4Rα−/lox and littermate IL-4Rα−/lox mice, we found that the
absence of IL-4Rα expressing B cells in mb1creIL-4Rα−/lox
mice led to significantly increased lung granuloma areas at
both 7 (65.271 ± 22.787 vs. 57.97 ± 21.099) and 14 days
(106.388 ±29.590 vs. 82.252 ± 31.763) post-challenge compared
to IL-4Rα−/lox littermate control mice. (Figures 3A,C). The
concentration of hydroxyproline was similar between all
mutants at 7 days post-challenge, however, mb1creIL-4Rα−/lox
mice had significantly increased fibrosis as indicated by high
concentrations of hydroxyproline at 14 days post-challenge
compared to littermate control mice (Figure 3B). Therefore,
we can conclude that IL-4Rα responsive B cells are required
to down-regulate granulomatous pathology and lung fibrosis
during synchronous S. mansoni egg challenge.
Impaired Secretion of Cytokines by B Cells
Deficient in IL-4Rα Signaling.
Having defined a critical role for IL-4Rα expressing B cells
in controlling the immune response and tissue pathology in
response to S. mansoni eggs, we proceeded to investigate the
immunological changes within the B cell population as a result
of IL-4Rα removal which might explain the observed changes.
Using the synchronous S. mansoni eggs challenge model, we
analyzed cytokine secretion by CD19+ B cells after restimulation
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with phorbol myristate (PMA) and ionomycin. The number
of B cells producing IL-4 and IL-10 in the mediastinal lymph
nodes was significantly reduced in mb1creIL-4Rα−/lox mice both
at 7 and 14 days post S. mansoni egg challenge compared
to littermate control mice (Figures 4A,B, Figure S4). We also
found that the number of follicular B cells (CD21hiCD23hi)
was reduced at 14 days post S. mansoni egg challenge in
B cell-specific IL-4Rα deficient mice compared to littermate
control mice (Figure 4C, Figure S4). Moreover, examination of
intracellular cytokine production by CD4+ T cells restimulated
with PMA/ionomycin ex vivo revealed that abrogation of IL-
4Rα expression on B cells indirectly resulted in significantly
reduced number of CD4+ T cells producing IL-4 (Figure 4D,
Figure S5), IL-10 (Figure 4E, Figure S5) and follicular helper T
cells (TFH) expressing CXCR5 (Figure 4F, Figure S5) compared
to littermate control mice at both time points (7 and 14 days
post eggs challenge). Taken together, these data suggest that the
absence of IL-4Rα from the B cell population impairs type-2
cytokine production by B cells, diminishes Th2 responses and
Tfh cell expansion resulting in a severely diminished pool of
follicular B cells in the lung-draining mediastinal lymph nodes
of mb1creIL-4Rα−/lox mice after synchronous S. mansoni eggs
challenge.
The Lack of B Cell-Derived IL-4 Impairs
Development of Th2 Responses in S.
Mansoni Infected B-IL-4−/− Mixed Bone
Marrow Chimeras
We had previously demonstrated that sorted B cells from
mb1creIL-4Rα-/lox mice displayed reduced IL-4 gene expression
at day 4 post-challenge with S. mansoni eggs in the footpad
compared to littermate control mice. To validate our observation
that deletion of IL-4Rα on B cells impairs the development of
optimal Th2 responses after S. mansoni infection by diminishing
IL-4 and IL-10 production by B cells, we generated mixed
bone marrow chimeras with a specific deficiency of B cell
derived IL-4 (Figure S6). Here, sub-lethally irradiated B cell-
deficient mice (µMT) were reconstituted with 50% µMT and
50% IL-4−/− bone marrow (BM) to generate mixed bone
marrow chimeras that lacked IL-4 production specifically on
B cells (B-IL-4−/−, Figure S6). As a control, recipient mice
were reconstituted with 100% Balb/c BM to generate wild-type
chimeras (WT), sufficient in IL-4 production in all hematopoietic
cells (Figure S6). Finally, recipient mice were reconstituted with
100 IL-4−/− BM to generate chimeras that had impaired IL-4
production in all hematopoietic cells (IL-4−/−, Figure S6). All
the bone marrow chimeras contained equivalent proportions
of CD3+CD4+ T cells (Figure S7A, CD19+B220+ B cells
(Figure S7B), CD11b+ cells (Figure S7C), and CD11c+ cells
(Figure S7D) in peripheral blood 8 weeks after reconstitution,
indicating successful reconstitution.
The efficiency of reconstitution was further confirmed by
analyzing antibody responses in sera of mixed bone marrow
chimeras that were infected with 100 live S. mansoni cercariae
and killed 7 week post-infection. WT and B-IL-4−/− chimeras
had similar titers of SEA-specific IgG1 and total IgE antibodies
after S. mansoni infection (Figures S8A,B). Conversely, WT and
B-IL-4−/− chimeras failed to produce antigen specific type 1
(IgG2a and IgG2b) antibody isotypes (Figures S8C,D). Infected
IL-4−/− chimeras failed to switch the class of antibody isotypes
as demonstrated by high titers of antigen specific type 1 antibody
isotypes (IgG2a and IgG2b) and reduced type 2 antibody isotypes
(Figures S8A–D). These data demonstrated that mice developed
sufficient type 2 antibody titers in response to S. mansoni
infection independently of B cell-derived IL-4.
Next, we investigated whether the lack of IL-4 expressing B
cells affected the development of Th2 responses after S. mansoni
infection. We stimulated total MLN cells from infected bone
marrow chimeras with SEA or α-CD3 and detected cytokine
production by ELISA from supernatants. Production of IL-4
was reduced in both B-IL-4−/− and IL-4−/− chimeras after
either antigen-specific or mitogenic stimulation compared to
WT controls (Figures 5A,B). Furthermore, the production of
IL-10 was significantly decreased while the production of IL-
17 was significantly increased both in B-IL-4−/− and IL-4−/−
chimeras after α-CD3 restimulation compared to WT controls
(Figure 5B). Finally, production of IFN-γ was increased in IL-
4−/− chimeras while it remained similar between B-IL-4−/− and
WT controls (Figure 5B).
We also analyzed intracellular cytokine secretion by B220+ B
cells after restimulation of total MLN cells with PMA/ionomycin
ex vivo and staining for flow cytometry analysis. The proportions
of CD19+B220+ B cells was similar between all the chimeras
(Figure 5C). Intracellular secretion of IL-4 by B220+ B cells
from B-IL-4−/− and IL-4−/− chimeras was significantly reduced
compared to WT chimeras (Figure 5D) while the levels of IFN-γ
remained comparable between all the chimeras (Figure 5E). IL-
4-producing B cells play a crucial role in the differentiation of
Th2 cells in vitro (5, 7). Although we did not find a difference
in the frequency of CD3+CD4+ T cells in chimeras lacking
B cell-derived IL-4 (Figure 5F), the frequency of CD3+CD4+
T cells producing IL-4 (Figures 5G,J) and IFN-γ (Figure 5H)
were comparable between B-IL-4−/− and WT chimeras whereas
the frequency of CD4+ T cells expressing Gata-3 (Figure 5I)
was significantly reduced in B-IL-4−/− chimeras compared to
WT controls.. The frequency of IL-4 (Figures 5G,J) and Gata-
3 (Figure 5I) expressing CD3+CD4+ T cells was significantly
reduced in IL-4−/− chimeras where IFN-γ (Figure 5H) was
unchanged compared to WT control chimeras. Therefore, these
data indicate that IL-4 producing B cells are crucial for driving
the development of Th2 responses during S. mansoni infection
in vivo.
DISCUSSION
In this study, we examined the role of IL-4Rα expressing B cells
in driving immunoregulation of inflammatory granulomatous
tissue pathology during schistosomiasis. We found that mice
carrying a specific deletion of IL-4Rα on B cells succumbed
quickly to schistosomiasis compared to littermate control and
B cell-deficient mice. Moreover, they failed to down-regulate
lung granuloma size compared to littermate control mice during
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FIGURE 4 | Abrogated cellular immunity in mice lacking IL-4 producing B cells after synchronous S. mansoni eggs challenged. Single cell suspensions were prepared
from mediastinal lymph nodes (MST) and cells were stained for flow cytometry. (A,B) Intracellular cytokine detection after stimulating total MST cells with 50 ng/ml
PMA and 250 ng/ml ionomycin in vitro. (C) Total number of follicular B cells (FO, CD19+CD23hiCD21hi) cells recruited to the mediastinal lymph node (MST). (D,E)
Total number of CD4+ T cells producing IL-4 and IL-10 in the MST. (F) Total number of CXCR5+ T follicular helper (TFH) cells in the lung draining lymph nodes. Data
are representative of two independent experiments. *p < 0.05, **p < 0.01 vs. IL-4Rα−/lox mice. n = 6 mice per group.
the S. mansoni egg challenge model. We also demonstrated that
mice lacking IL-4Rα expressing B cells have enlarged liver and
gut granulomas, and display a mixed cytokine profile indicated
by augmented secretion of Th1, Th2, and Th17 cytokines at
24 weeks post-infection. Altogether, we could conclude that IL-
4Rα expressing B cells are crucial for containment of excessive
granulomatous tissue pathology and dampening of exuberant
cytokine production during chronic schistosomiasis.
The contribution of B cells in driving host resistance to
schistosomiasis is well established in the literature (1, 2). In
fact, a study by Jankovic et al. demonstrated the importance
of FcRγ expression on B cells in regulating excessive tissue
pathology during both the acute and chronic phases of infection
(1). In this study, we questioned whether a specific deletion of
IL-4Rα expression on B cells could recapitulate the impaired
host survival as a result of the general lack of B cells
during S. mansoni infection. Interestingly, we found that B
cell-specific IL-4Rα-deficient mice were highly susceptible to
schistosomiasis suggesting that the lack of IL-4Rα expression
on B cells, similarly to complete B-cell depletion sufficiently
prevents the development of host protective immunity during
schistosomiasis. These data suggest that B cells may be principally
important in the regulation of tissue inflammation, whereas IL-
4Rα expression on B cells may be crucial for the regulation
of tissue inflammation and orchestrating host protective Th2
immunity. The observed delayed susceptibility of B cell deficient
mice can potentially be explained by the 5-fold increased
production of IL-10 by T cells after restimulation with α-
CD3 compared to both B cell-specific IL-4Rα-deficient mice
and littermate control mice. IL-10 has been implicated as
a key immunoregulatory factor driving host resistance to
schistosomiasis (23, 42). The fact that 50% of B cell deficient
mice succumbed to disease at the beginning of the chronic
stage of infection suggests that the mechanism of death may be
different from that operating in B cell-specific IL-4Rα-deficient
mice. Studies by Hoffman et al. and others have demonstrated
that the mechanism of death can differ depending on the
balance of the immune response, with mice having a skewed
Th1 response succumbing early during infection due to cachexia
and endotoxemia while mice with a skewed Th2 response die at
the chronic stage of infection with increased fibrosis and large
granulomas (22, 23, 32, 42).
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FIGURE 5 | Impaired Th2 immunity in mice lacking IL-4 producing B cells. Bone marrow chimeras were infected with 100 live S. mansoni cercariae and killed 7 weeks
post-infection. Single cell suspensions were prepared from MLN and cells were restimulated with 20µg/ml SEA or α-CD3 in vitro. (A,B) Cytokine production by
restimulated total MLN cells was detected by ELISA. (C) Frequency of CD19+B220+ B cells in the gut draining lymph node. (D,E) Detection of intracellular cytokines
produced by CD19+ B cells after restimulation of total MLN cells with 50 ng/ml PMA and 250 ng/ml ionomycin. (F) Frequency of CD3+CD4+ T cells in the MLN.
(G,H) Intracellular cytokine production by CD3+CD4+ T cells after stimulation of total MLN cells with 50 ng/ml PMA and 250 ng/ml ionomycin. (I) Frequency of
CD3+CD4+ T cells expressing Gata-3. (J) Dot plot showing gating on IL-4 producing CD4+ T cells by infected WT, B-IL-4−/− and IL-4−/− chimeras. Data are
representative of two independent experiments. n = 4–6 mice.
The expansion and differentiation of cytokine producing T
cells has been shown to be largely dependent on B cells (3,
7, 13). In our study, we found no significant difference in the
absolute number of CD3+CD4+ T cells between all the mutant
mouse strains. However, the expansion of follicular helper T
cells (TFH) in the secondary lymphoid tissue was significantly
impaired in mb1creIL-4Rα−/lox mice and µMT mice compared
to littermate control mice. TFH cells are crucial for lymphoid
tissue organization by assisting in germinal center formation and
promote antibody responses including isotype switching (43–
45). In a study by Lin and colleagues, the deficiency of B cells
was shown not to alter the differentiation of antigen-specific
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T cells and expression of activation markers CD69 and CD44
(7). Likewise, the expansion of effector CD4+ T cells was not
hindered in B cell-specific IL-4Rα deficient mice whereas IL-
4Rα−/− mice displayed significantly reduced absolute numbers
of effector CD4+ T cells compared to littermate control mice.
Importantly, the lack of IL-4Rα expression on B cells resulted
in abrogated intracellular production of Th2 cytokines IL-4 and
IL-13 by CD4+ T cells after restimulation with PMA/Ionomycin
ex vivo, suggesting that IL-4/IL-13 responsive B cells are crucial
for promoting the expansion Th2 cells. Indeed, previous studies
have shown that the lack of B cells alters the expansion and
differentiation of IL-4 producing effector Th2 cells in response
to Hp infection in vivo (3). Furthermore, B cells mediate
the expansion of primary Th2 cells in response to protein
antigens delivered with Nippostrongylus brasiliensis (Nb) (7) and
protein antigens delivered with alum (4). B cells have also been
shown to contribute to susceptibility during Leishmania major
LV 39 infection in Balb/c mice and promote Th2 immunity
(9).
Although there was no significant difference in the absolute
number of CD19+B220+ B cells recruited into the MLN
of infected mice, the number of follicular (FO) B cells was
significantly reduced in both mb1creIL-4Rα−/lox compared to
littermate control mice. Conversely, the number of marginal zone
(MZ) B cells was significantly increased in B cell-specific IL-4Rα
deficient mice compared to littermate control mice. FO B cells
are found within germinal centers where they form tight physical
contact with T cells, thus ensuring optimal T cell proliferation
(46). B cells have been shown to produce Th2 cytokines in
response to Hp infection in vivo (3, 13). The number of IL-
4 and IL-13 producing B cells was reduced in both mb1creIL-
4Rα−/lox and µMT mice after restimulation of total MLN
cells with PMA/Ionomycin compared to the littermate control
mice. Therefore, IL-4/IL-13 responsive B cells are important for
maintaining optimal cellular immunity during infection with S.
mansoni.
Down-modulation of the immune response and controlling
the size of newly formed granulomas is essential for the
host to survive chronic schistosomiasis (36, 37, 39, 47, 48).
Earlier studies implicated CD8+ suppressor cells (36) and cross
regulatory cytokines produced by CD4+ T cells (39, 49) in
regulating exuberant host immune responses during the chronic
stages of S. mansoni infection. However, a subsequent study by
Yap et al. demonstrated a dispensable role for CD8+ T cells
and IFN-γ in immunoregulation of tissue pathology during
chronic schistosomiasis (47). We have recently shown that
interfering with IL-4Rα signaling during the chronic phase
of infection can ameliorate fibrogranulomatous pathology and
reduce tissue scarring without being detrimental to host survival
during chronic schistosomiasis (48). Of relevance to the current
study, B cells have been shown to down-regulate granuloma
formation without altering T cell responsiveness during chronic
schistosomiasis (1, 2). A study by Fairfax and colleagues
showed that blocking IL-10R resulted in the loss of B cells in
the liver, consequently driving severe disease characterized by
portosystemic shunting of the eggs to the heart and lungs during
chronic schistosomiasis (41). Since we had established that
deleting IL-4Rα expression on B cells impairs the development
of type 2 instructing B effector cells, we next asked whether such
cells were required for immunoregulation of fibrogranulomatous
tissue inflammation during chronic schistosomiasis. We found
that B cell-specific IL-4Rα-deficient mice had significantly larger
granulomas at both 16 and 24 weeks post-infection compared
to littermate control mice, suggesting that IL-4Rα expressing
B cells are required to downregulate granulomatous pathology
during chronic schistosomiasis. However, when comparing liver
granuloma sizes of mb1creIL-4Rα−/lox mice between the two time
points, we found that the granulomas at 24 weeks postinfection
were smaller than those at 16 weeks post-infection. A similar
trend was observed in littermate control mice, indicating the
existence of a common immunomodulatory mechanism(s) still
operating in the two strains. Interestingly, with the exception
of IL-10, we found comparable cytokine responses between the
two strains at 16 weeks post-infection. Such a reduction in IL-
10 production tightly aligns with the high concentrations of
α-CD3-driven IL-4, IL-5, IL-6, IL-10, IL-17, and IFN-γ that
were observed at 24 weeks postinfection in the supernatants
of total lymph node cell cultures from B cell-specific IL-4Rα-
deficient mice when compared to those from littermate control
mice. Tentatively, a case could be made for the importance of
IL-4Rα expressing B cells in driving IL-10 production among
other type-2 governed processes to ensure the control of
acute granulomatous inflammation T cell responses and the
resolution of excessive cytokine production during experimental
schistosomiasis.
After establishing the requirement for IL-4Rα signaling on B
cells in the development of IL-4 producing B cells and optimal
Th2 responses to acute schistosomiasis, we questioned whether
the development of optimal Th2 responses depends on both
the ability of B cells to receive instruction from IL-4 and their
ability to secrete IL-4 that triggers Th2 responses during S.
mansoni infection. It had been previously shown that the lack
of IL-4 producing B cells during Hp infection did not hamper
parasite clearance, indicating that the development of protective
immunity occurred independently of B cell-derived IL-4 (10).
In contrast, using mixed bone marrow chimeras lacking B cell-
derived IL-4 (B-IL-4−/−), we observed that secretion of IL-4
was significantly reduced after both antigen-specific stimulation
and mitogenic stimulation with α-CD3 in cells from B-IL-4−/−
chimeras, similar to IL-4−/− chimeras. Moreover, IL-10 was
significantly reduced in cells from chimeras lacking B cell-derived
IL-4 after mitogenic stimulation. This was later confirmed by
analyzing intracellular cytokine production and transcription
factor expression in CD4+ T cells, as we found significantly
reduced frequencies of IL-4, IL-10, and Gata-3 expressing CD4+
T cells in B-IL-4−/− chimeras compared to controlWT chimeras.
These results demonstrate that both the ability of B cells to receive
instruction via IL-4Rα and B cell-derived IL-4 are essential for
development of Th2 responses during acute schistosomiasis.
These data corroborate our earlier findings, where we showed
that chimeras lacking B cell-derived IL-4 had a skewed Th1
response characterized by up-regulation of the Th1 cytokine IFN-
γ and down-regulation of the Th2 cytokines IL-4 and IL-13, that
consequently rendered these mice resistant to L. major induced
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cutaneous leishmaniasis (9). Here, we have focused on B cell-
derived IL-4, however, we cannot discount the involvement of
other B cell-derived cytokines in driving development of Th2
immunity in response to helminth infections. In fact, a study by
Wojciechowski et al. implicated B cell-derived TNF-α and IL-2
in mediating clearance of Hp infection, development of CD4+ T
cells secreting IL-4 and secretion of protective type 2 antibody
isotypes (10).
In summary, we have demonstrated that selective deletion
of IL-4Rα on B cells renders mice more susceptible to
acute schistosomiasis than B-cell deficient mice. We also
unprecedentedly showed that IL-4Rα expressing B cells are
required for immunoregulation of fibrogranulomatous tissue
pathology and T cell responses during the late stages of chronic
schistosomiasis. Our data therefore argue for the potential
benefits of boosting IL-4Rα-mediated responses specifically
on B cells to ameliorate fibrogranulomatous pathology
associated with chronic schistosomiasis, especially in endemic
areas.
MATERIALS AND METHODS
Generation and Genotyping of
mb1creIL-4Rα−/lox Balb/c Mice
Mb1cre mice were intercrossed with IL-4Rαlox/lox Balb/c mice
(32, 50–52). These mice were further mated with homozygous
IL-4Rα−/− Balb/c mice (43) to generate hemizygous mb1creIL-
4Rα−/lox mice (9). Hemizygous littermates (IL-4Rα−/lox)
expressing functional IL-4Rα were used as wild-type controls in
all experiments. Mice were genotyped as described previously
(32, 43). All mice were housed in specific pathogen-free barrier
conditions in individually ventilated cages at the University of
Cape Town biosafety level 2 animal facility. Experimental mice
were age and sex matched and used between 8 and 12 weeks of
age.
Ethics Statement
This study was performed in strict accordance with the
recommendations of the South African national guidelines
and University of Cape Town practice of laboratory animal
procedure. All mouse experiments were performed according
to the protocols approved by the Animal Research Ethics
Committee of the Faculty of Health Sciences, University of
Cape Town (protocol number: 010/041). Efforts were made to
minimize and reduce suffering of animals.
Live S. Mansoni Infection of Mice
Mice were percutaneously infected with 100 live cercariae
(acute infection) or 30 live cercariae (chronic infection) that
were provided by the Schistosome Research Reagent Resource
Center for distribution by BEI Resources, (NIAID, NIH,
USA). Schistosomamansoni, Strain NMRI Exposed Biomphalaria
glabrata, Strain NMRI, NR-21962. Mice were monitored weekly
until the endpoint was reached (7 weeks for acute, 16 and 24
weeks for chronic schistosomiasis).
Pulmonary S. Mansoni Eggs Model
Synchronous S. mansoni egg-challenge was conducted as
previously described (44). Briefly, mice were sensitized
to schistosome eggs by intraperitoneal injection of 2,500
eggs. Mice were subsequently challenged 14 days later by
intravenous injection of 2,500 eggs and killed at day 7 and 14
post-challenge.
Cell Preparation and ex vivo Restimulation
Single cell suspensions were prepared by pressing the
draining lymph nodes through 70µM cell-strainers. Cells
were resuspended in complete IMDM (Gibco) supplemented
with 10% FCS (Gibco) and penicillin and streptomycin (100
U/ml and 100µg/ml, Gibco). The cells were cultured at 2 ×
106 cells/ml in 48-well plates coated with α-CD3 (20µg/ml)
or soluble egg antigen (SEA, 20µg/ml) and incubated at 37◦C
in a humidified atmosphere containing 5% CO2. Supernatants
were collected after 72 h and cytokines were measured by ELISA.
Quantities of IL-4, IL-5, IL-10, IL-17, and IFN-γ were measured
by sandwich ELISA as previously described (43).
Antibodies and Flow Cytometry
The following antibodies comprising the B cell antibody panel
were used: B220-V500, CD19-PerCP Cy5.5, CD23-PE, CD21-
APC, CD24-PECy7, CD86-V450, MHCII-FITC, and IgM-Biotin
(BD Bioscience, Erembodegem, Belgium). T cells panel consisted
of the following antibodies: CD4-PerCP, CD3-AlexaFluor 700,
CD62L-V500, CD44-FITC, CD28-PE, and CXCR5-V450 (BD
Bioscience, Erembodegem, Belgium). Cells were acquired on a
FACS Fortessa machine (BD Immunocytometry system, San Jose,
CA, USA) and data was analyzed using Flowjo software (Treestar,
Ashland, OR, USA).
Intracellular Cytokine Staining
For detection of intracellular cytokines MST from S. mansoni
eggs injected mice were plated at 2 × 106 cells/well and
stimulated at 37◦C for 4 h with 50 ng/ml phorbal myristate
acetate (PMA), 250 ng/ml ionomycin and 200µM monensin in
IMDM/10% FCS (all purchased from Sigma-Aldrich). Cells were
stained with extracellular markers (CD4 Biotin-APC, or CD19
PercP), fixed for 30min on ice in 2% (w/v) paraformaldehyde
and permeabilised with 0.5% saponin buffer and stained with
PE-labeled anti-mouse IL-4 and IL-10 for 30min. Acquisition
was performed using a FACSCalibur (BD Immunocytometry
Systems, San Jose, CA, USA) and data were analyzed using
FlowJo software (Treestar, Ashland, OR, USA).
Enzyme Linked Immunosorbent Assays
(ELISAs)
Cytokines in supernatant were measured by sandwich ELISA
as previously described (43). For antibody ELISAs, blood
was collected in serum separator tubes (BD Bioscience, San
Diego, CA) and serum was separated by centrifugation at
8 000 ×g for 10min at 4◦C. Titres of SEA-specific IgG1,
IgG2a, IgG2b, and total IgE were determined as previously
described (43).
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Hydroxyproline Assay
Hydroxyproline content as a measure of collagen production
was determined using a modified protocol (45). Briefly,
weighed liver samples were hydrolyzed and added to a 40mg
Dowex/Norit mixture. The supernatants were neutralized with
1% phenolphthalein and titrated against 10M NaOH. An
aliquot was mixed with isopropanol and added to chloramine-
T/citrate buffer solution (pH 6.5). Erlich’s reagent was added
and absorbance was read at 570 nm. Hydroxyproline levels
were calculated using 4-hydroxy-L-proline (Calbiochem) as a
standard, and results were expressed as µmoles hydroxyproline
per weight of tissue that contained 104 eggs.
Histology
Liver and gut samples were fixed in 4% (v/v) formaldehyde
in phosphate buffered saline, embedded in wax and processed.
Sections (5–7µm) were stained with hematoxylin and eosin
(H&E) and analine blue solution (CAB) and counterstained with
Wegert’s hematoxylin for collagen staining. Micrographs of liver
granuloma were captured using a Nikon 5.0 mega pixel color
digital camera (DCT DS-SMc).The diameter of each granuloma
containing a single egg was measured with the ImageJ 1.34
software. An average of 25 granulomas per mouse was included
in the analyses.
Statistics
Statistical analysis was conducted using GraphPad Prism 4
software. Data was calculated asmean± SD. Statistical significant
was determined using the unpaired Student’s t-test or 2-way
ANOVA with Bonferroni’s post test, defining differences to IL-
4Rα−/lox mice as significant (∗p≤ 0.05; ∗∗p≤ 0.01; ∗∗∗p≤ 0.001;
Prism software; http://www.prism-software.com).
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Figure S1 | Reduced Th2 immunity in B cell-specific IL-4Rα-deficient mice.
IL-4Rα−/lox, mb1cre IL-4Rα−/lox, and µMT mice were infected with 100 live
S. mansoni cercariae and analyzed 7 weeks post-infection. Single cell suspension
was prepared from mesenteric lymph node (MLN) and cells were stained for flow
cytometry analysis. (A) Recruitment of CD3+CD4+ T cells into the secondary
lymphoid tissue. (B,C) Expansion of CXCR5+ TFH cells and effector CD4
+ T cells
(CD4+CD44hiCD62Llo) in the MLN. (D) Intracellular cytokine detection after
restimulation of MLN cells with 50 ng/ml PMA and 250 ng/ml ionomycin in vitro.
(E–G) Recruitment of CD19+B220+ B cells, follicular B cells (FO,
B220+CD21hiCD23hi) and marginal zone B cells (MZ, B220+CD21hiCD23lo) into
the secondary lymphoid tissue. (H) Analysis of intracellular cytokine production by
CD19+ B cells after restimulation of total MLN cells with 50 ng/ml PMA and
250 ng/ml ionomycin in vitro. Data represents 3 independent experiments. n =
4–6 mice. ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗p < 0.001 vs. IL-4Rα−/lox mice.
Figure S2 | The absence of IL-4Rα responsive B cells leads to augmented gut
inflammation in B cell-specific IL-4Rα-deficient mice during chronic
schistosomiasis. IL-4Rα−/lox, mb1cre IL-4Rα−/lox and IL-4Rα−/lox mice were
infected with 30 S. mansoni cercariae and analyzed at 16 and 24 weeks
post-infection. Histological examination of gut tissue after staining sections with
H&E (×100). Data represent two independent experiments. n= 4–6 mice per
group.
Figure S3 | Comparable numbers of eggs in the lungs of infected mice at the
chronic stages of schistosomiasis. IL-4Rα−/lox, mb1cre IL-4Rα−/lox and
IL-4Rα−/lox mice were infected with 30 S. mansoni cercariae and analyzed at 16
and 24 weeks post-infection. Lungs were collected and the tissue was hydrolyzed
overnight in 5% KOH and eggs were enumerated under a light microscope. (A)
Egg numbers in the lungs at 16 weeks post-infection. (B) Egg numbers in the
lungs at 24 weeks post-infection.
Figure S4 | Gating strategy for B cells. Single cell suspensions were prepared
from MLN and cells were stained for flow cytometry. Data was analyzed on FlowJo
software and B cells were analyzed by gating on single cells, lymphocytes and
CD19+B220+ B cells. CD21 and CD23 staining was used to delineate FO and
MZ cells.
Figure S5 | Gating strategy for CD4+ T cells. Single cell suspensions were
prepared from MLN and cells were stained for flow cytometry. Data was analyzed
on FlowJo software and CD4+ T cells were analyzed by gating on single cells,
lymphocytes and CD3+CD4+ T cells. CD4+CD44hiCD62Llo was used to
delineate effector memory T cells and CD4+CXCR5+ T cells were T follicular
helper (TFH) cells.
Figure S6 | Schematic showing the generation of mixed bone marrow chimeras.
Irradiated µMT mice were reconstituted 100% Balb/c BM (WT), 50% µMT and
50% IL-4−/− BM (B-IL-4−/−) or 100% IL-4−/− BM (IL-4−/−) and allowed to
reconstitute for 8 weeks.
Figure S7 | Successful reconstitution of bone marrow chimeras. Irradiated µMT
mice were reconstituted 100% Balb/c BM (WT), 50% µMT and 50% IL-4−/− BM
(B-IL-4−/−) or 100% IL-4−/− BM (IL-4−/−) and allowed to reconstitute for 8
weeks. Mice were bled at 8 weeks and cells were stained for flow cytometry
analysis. (A) Proportions of CD3+CD4+ T cells in peripheral blood after
reconstitution. (B) Proportions of CD19+B220+ B cells found in blood after
reconstitution. (C) Frequency of CD11b+ cells in peripheral blood. (D) Frequency
of CD11c+ cells found in peripheral blood after reconstitution of bone marrow
chimeras. Data represent two independent experiments. n = 6 mice per group.
Figure S8 | Sufficient humoral immunity develops in mice lacking IL-4 producing
B cells during S. mansoni infection. Irradiated µMT mice were reconstituted with
100% Balb/c bone marrow cells (WT), 50% µMT and 50% IL-4−/− bone marrow
cells (B-IL-4−/−) or 100% IL-4−/− bone marrow cells (IL-4−/−) and infected with
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100 S. mansoni cercariae. Mice were killed 7 weeks post-infection and blood was
collected for serum separation. (A–D) Serum antibody titers detected by ELISA.
Data represent two independent experiments. ∗p < 0.05 vs. WT mice. n = 4–6
mice per group.
Table S1 | Percentage of mice that died during the course of the chronic
schistosomiasis. Mice were infected with 30 live S. mansoni cercariae and killed at
16 and 24 weeks post-infection.
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